COVID-19 Serotherapy Concept

subject area of

• Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis  Journal Articles
• Brazilian guidelines for the treatment of outpatients with suspected or confirmed COVID-19. A joint guideline of the Brazilian Association of Emergency Medicine (ABRAMEDE), Brazilian Medical Association (AMB), Brazilian Society of Angiology and Vascular Surgery (SBACV), Brazilian Society of Geriatrics and Gerontology (SBGG), Brazilian Society of Infectious Diseases (SBI), Brazilian Society of Family and Community Medicine (SBFMC), and Brazilian Thoracic Society (SBPT)  Journal Articles
• COVID-19 convalescent plasma: Interim recommendations from the AABB.  Journal Articles
• Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma  Journal Articles
• Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial  Journal Articles
• Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial  Journal Articles
• Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial  Journal Articles
• Diretrizes Brasileiras para o tratamento farmacológico de pacientes hospitalizados com COVID-19  Journal Articles
• Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19  Journal Articles
• Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis  Journal Articles
• Efficacy of convalescent plasma for treatment of COVID-19 in Uganda  Journal Articles
• Feasibility of collecting and processing of COVID-19 convalescent plasma for treatment of COVID-19 in Uganda  Journal Articles
• In patients hospitalized with COVID-19, adding convalescent plasma to usual care did not reduce 28-d mortality  Journal Articles
• Lessons learned from the CONCOR‐1 trial  Journal Articles
• Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses  Journal Articles
• Pregnancy and COVID‐19: pharmacologic considerations  Journal Articles
• Quality of life and cost‐effectiveness of convalescent plasma compared to standard care for hospitalized COVID‐19 patients in the CONCOR‐1 trial  Journal Articles
• Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19  Journal Articles
• Retention of hemostatic and immunological properties of frozen plasma and COVID‐19 convalescent apheresis fresh‐frozen plasma produced and freeze‐dried in Canada  Journal Articles
• Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R.1 Lineage Variants, Canada  Journal Articles
• Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update  Journal Articles
• The II Brazilian Guidelines for the pharmacological treatment of patients hospitalized with COVID-19 Joint Guidelines of the Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Cirurgia Vascular, Sociedade Brasileira de Infectologia, Sociedade Brasileira de Pneumologia e Tisiologia and Sociedade Brasileira de Reumatologia  Journal Articles